Mahoney Michael F purchased $9.0M of BSX
Mahoney Michael F (Chairman, President & CEO) purchased 186,240 shares of BOSTON SCIENTIFIC CORP (BSX) at $48.33 ($9.00M total) on 2026-08-03.
How this was made
The 30-second read
Why it matters
The newest fact is the CEO’s open-market purchase of 186,240 shares at $48.3323 on 2026-08-03, filed on 2026-08-05.
Market read
Traders may treat the filing as a small sentiment input, but it does not introduce new fundamentals in the provided text.
What to watch
The article provides no context on prior insider activity, option exercises, or whether the CEO’s holdings are already large, limiting inference from the $9.0M figure.
Background
The article is a SEC Form 4 insider transaction disclosure for Boston Scientific (BSX).
Ticker impact
Boston Scientific CEO Michael F Mahoney bought 186,240 shares in an open-market Form 4 transaction worth about $9.0M.
Likely limited near-term impact; any effect should be small and sentiment-driven.
The filing is a primary-source Form 4 and the buy size is notable, but there is no accompanying guidance, deal, or operational update in the text.
Market effects
No sector-wide implications are disclosed; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Insider buys can be driven by diversification, liquidity needs, or routine planned activity; the filing notes no 10b5-1 plan but does not prove conviction.
Key entities
- issuerBoston Scientific
Subject of the Form 4 insider transaction disclosure.
- insiderMichael F Mahoney
Chairman, President and CEO who purchased shares.
